Common Names: blackberry lily
BCE from traditional Chinese medicine inhibits NSCLC cell growth by inducing apoptosis and blocking key signaling pathways, suggesting potential as a treatment for NSCLC, particularly in patients with Ras or Raf mutations.
BCP80-2 polysaccharide from Belamcanda chinensis inhibits tumor growth, metastasis, and angiogenesis in zebrafish. It suppresses cell migration via FAK pathway and boosts immune response.
Belamcanda chinensis (BC), a traditional Chinese medicine, has anti-inflammatory and immune regulatory properties that can help counteract asthma, a serious and chronic inflammatory disease of the airways. This research is important for finding potential treatments for asthma.
A recent study identified several compounds isolated from a specific plant species. These compounds were tested for their effects on tumor cell growth and metastasis. One compound in particular showed significant activity against two different types of breast cancer cells. Further investigation revealed that this compound caused cell cycle arrest, mitochondrial damage, and cell apoptosis. These findings suggest that this compound could be a potential treatment for triple-negative breast cancer. More research is needed to fully evaluate its effectiveness.
This study found that extract improved asthma symptoms in guinea pigs by affecting immune mechanisms, inflammation, nerve metabolism, and energy metabolism. The treatment effects varied based on sex.